TRC160334

• UNSPSC Description:

  TRC160334 is a hypoxia-inducible factor (HIF) hydroxylase inhibitor. TRC160334 can be used for the research of ischemia/reperfusion injury[1].

• Target Antigen:

  HIF/HIF Prolyl-Hydroxylase

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/trc160334.html

• Solubility:

  DMSO : 25 mg/mL (ultrasonic;warming;heat to 80°C)

• Smiles:

  O=C(C1=C(O)N=C(SC2=C3CCCCC2)N3C1=O)NCC(O)=O

• Molecular Weight:

  337.35

• References & Citations:

  [1]Jamadarkhana P, et al. Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury. Am J Nephrol. 2012;36(3):208-218.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1293289-69-6